After the news of Pfizer Inc.’s plan to merge its established products subsidiary Upjohn with generics major Mylan Pharmaceuticals Inc. to create the world's biggest generics group by revenues, many are wondering if the move means Upjohn will retreat from its newly opened global headquarters in Shanghai.
During the opening ceremony for the Chinese facility, Pfizer Upjohn president Michael Goettler told Scrip that the main reason to choose Shanghai, the hub of China's pharma industry, was to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?